📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance. (2018)

First Author: Yao S

Attributed to: Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.semcancer.2017.11.018

PubMed Identifier: 29180117

Publication URI: http://europepmc.org/abstract/MED/29180117

Type: Journal Article/Review

Volume: 50

Parent Publication: Seminars in cancer biology

ISSN: 1044-579X